GB1300567A - Therapeutic compositions - Google Patents
Therapeutic compositionsInfo
- Publication number
- GB1300567A GB1300567A GB6217269A GB6217269A GB1300567A GB 1300567 A GB1300567 A GB 1300567A GB 6217269 A GB6217269 A GB 6217269A GB 6217269 A GB6217269 A GB 6217269A GB 1300567 A GB1300567 A GB 1300567A
- Authority
- GB
- United Kingdom
- Prior art keywords
- virus
- particles
- mould
- animal
- rna
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P19/00—Preparation of compounds containing saccharide radicals
- C12P19/26—Preparation of nitrogen-containing carbohydrates
- C12P19/28—N-glycosides
- C12P19/30—Nucleotides
- C12P19/34—Polynucleotides, e.g. nucleic acids, oligoribonucleotides
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- General Health & Medical Sciences (AREA)
- General Engineering & Computer Science (AREA)
- Botany (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Alternative & Traditional Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medical Informatics (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
1300567 Anti-viral material from Penicillium stoloniferum BEECHAM GROUP Ltd 9 Dec 1970 [20 Dec 1969] 62172/69 Heading A5B Animals other than human beings are protected against virus infection by administering to the animal a composition consisting of or comprising virus-like particles obtained from the mould Penicillium stoloniferum. Preferably the composition contains both virus-like particles and free double-stranded ribonucleic acid or a salt thereof, said RNA being obtained from the virus-like particles of the mould Penicillium stoloniferum. The compositions may be administered topically or by systemic injection to the animal before it becomes infected with the infective virus and may be administered on repeated occasions during the period when the animal is susceptible to infection. Protection has been achieved in a variety of animals, e.g. against Coxsackie B1 virus, Semliki Forest virus, vaccinia virus, foot and mouth disease virus, vesicular stomatitis virus, rabies virus and influenza virus. Virus-like particles having antiviral activity can be extracted from a medium in which the mould Penicillium stoloniferum has been grown by separating the mycelium of the mould from a culture medium in which it has been grown, treating the culture medium with RNA or a salt thereof, adjusting the pH of the resulting liquor to a pH of 3 to 6, separating the resulting precipitate from the supernatant, concentrating and purifying a suspension of the precipitate, e.g. by ultrafiltration and differential sedimentation, to yield the virus-like particles. Double-stranded RNA can be extracted from the virus-like particles so obtained by deproteinisation.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB6217269A GB1300567A (en) | 1969-12-20 | 1969-12-20 | Therapeutic compositions |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB6217269A GB1300567A (en) | 1969-12-20 | 1969-12-20 | Therapeutic compositions |
Publications (1)
Publication Number | Publication Date |
---|---|
GB1300567A true GB1300567A (en) | 1972-12-20 |
Family
ID=10487927
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB6217269A Expired GB1300567A (en) | 1969-12-20 | 1969-12-20 | Therapeutic compositions |
Country Status (1)
Country | Link |
---|---|
GB (1) | GB1300567A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2427098A1 (en) * | 1978-06-03 | 1979-12-28 | Boehringer Sohn Ingelheim | PREPARATIONS BASED ON RIBONUCLEIC TRANSFER ACIDS, WITH ANTIVIRAL ACTIVITY |
-
1969
- 1969-12-20 GB GB6217269A patent/GB1300567A/en not_active Expired
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2427098A1 (en) * | 1978-06-03 | 1979-12-28 | Boehringer Sohn Ingelheim | PREPARATIONS BASED ON RIBONUCLEIC TRANSFER ACIDS, WITH ANTIVIRAL ACTIVITY |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2001019380A3 (en) | Oncolytic virus | |
EP0025719A3 (en) | Gamma-globulin preparation for intravenous administration, process for production thereof and process for preparation of gamma-globulin of low anticomplementary activity | |
BG86132A (en) | PYRIDAZINAMINE DERIVATIVES | |
ATE20309T1 (en) | PHARMACEUTICAL PREPARATION. | |
DE2435746C2 (en) | ||
Kern et al. | Herpesvirus hominis infection in newborn mice: treatment with interferon inducer polyinosinic-polycytidylic acid | |
GB1300567A (en) | Therapeutic compositions | |
JPS5676401A (en) | Simple glucan separated from cultured choray, preparation thereof and antitumor agent containing its polysaccharide as effective component | |
US4049794A (en) | Treatment of infections in animals | |
Carroll et al. | Resistance of visna virus to interferon | |
BE760760A (en) | NEW DERIVATIVES OF 9-AZOLYL-FLUORENE-9-CARBOXYLIC ACID, THEIR PROCESS OF PREPARATION AND THEIR APPLICATION TO THE REGULATION OF PLANT GROWTH | |
CA2258675A1 (en) | 2-cyclopenten-1-one as an inducer of hsp70 | |
GB1187830A (en) | Pharmaceutical Compositions comprising Polynucleotides | |
JPS6120525B2 (en) | ||
ES350690A1 (en) | Concentration and purification of influenza viruses | |
US3952103A (en) | Herpes viral infection treatment | |
IE32044B1 (en) | Process for the manufacture of a tetanus-vaccine | |
IE32015L (en) | Producing interferon inducer | |
Hashimoto et al. | The Mode of Production of Endotoxin‐Induced Interferon in Rabbit Tissue Cells: I. Development of Priming by Pretreatment with Interferon | |
GB1300259A (en) | Biologically active material | |
SU1522486A1 (en) | Method of preparing of substance showing hepatoprotective activity | |
RU2012352C1 (en) | Antivirus composition | |
Furusawa et al. | Antiviral activity of tobacco leaf on encephalomyocarditis (EMC) virus infection | |
USD228051S (en) | Study carrel | |
GB1254744A (en) | Antiviral ribonucleic acid substance |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PS | Patent sealed | ||
PLNP | Patent lapsed through nonpayment of renewal fees |